Ignite Creation Date:
2025-12-24 @ 2:12 PM
Ignite Modification Date:
2025-12-25 @ 12:51 PM
Study NCT ID:
NCT07207395
Status:
RECRUITING
Last Update Posted:
2025-10-06
First Post:
2025-10-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Orally Administered JBI-802 Alone or in Combination With Pembrolizumab for Patients With Non-small Cell Lung Cancer With an STK11 Mutation.
Sponsor:
The Christ Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-04-29
Start Date Type:
ACTUAL
Primary Completion Date:
2027-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-10
Completion Date Type:
ESTIMATED
First Submit Date:
2025-10-02
First Submit QC Date:
None
Study First Post Date:
2025-10-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-02
Last Update Post Date:
2025-10-06
Last Update Post Date Type:
ESTIMATED